Clinical trials recruiting in Setagaya-ku, Japan
10
Recruiting trials
11
Conditions
Phase breakdown
Phase 2 2Phase 3 7Not applicable 2
Conditions recruiting in Setagaya-ku, Japan
Recruiting trials in Setagaya-ku, Japan
- A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
- A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
- Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)
Common questions
How many clinical trials are recruiting in Setagaya-ku, Japan?
10 recruiting trials have at least one study site in Setagaya-ku, Japan.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.